content-image

Achelous Partners Advises GeneMedix plc (LSE: GMX) on its Proposed Restructuring involving a £32.1 million Proposed Strategic Investment by Reliance Life Sciences Pvt Ltd, part of the Reliance Group, India’s Largest Private Sector Enterprise

GeneMedix plc (“GeneMedix” or “the Company”), the UK biopharmaceutical company listed on the London and Singapore Stock Exchanges, announces details of its proposed restructuring and move to AIM.

Categories : Uncategorized ,